🔥今日熱門話題: pfizer

2024-04-24 02:45:49 | 香港

關於pfizer

pfizer

1. Pfizer 2,000+
2023-01-29 13:00
輝瑞被指考慮「研發變種新冠病毒」公司否認美國右翼調查組織「真相工程」（Project Veritas）1月25日發布一段影片顯示一位被稱為Jordon Trishton Walker、被指是美國輝瑞藥廠（Pfizer）研發. 周日法甲，巴黎聖日耳門三大球星美斯、尼馬和基利安麥巴比自世界盃後首次一同正選上陣，然而在補時階段主場被蘭斯絕殺逼和1：1。聖日耳門踏入二三年後於聯賽只得一勝， ... PSG三巨頭世盃後首同場正選惟被蘭斯絕殺逼和1：1

本頁為pfizer專題，實時追踨搜集關於pfizer的網上資料，全因2024年04月24日在香港引起了大量網友討論及關注。讀者可按自己興趣或需要，閱讀以下專題相關新聞或文章。

pfizer 背景

Pfizer closes R&D unit that spawned $7.1B anti-TL1A med - Fierce Biotech Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution - Pfizer Pfizer to reduce stake in Haleon from 32% to 25% with $2.6B sale - Fierce Pharma Use of the Pfizer Respiratory Syncytial Virus Vaccine ... - 衛生署疾病管制局 13 Things To Know About Paxlovid, the Latest COVID-19 Pill - Yale Medicine Pfizer focuses on long COVID in latest 'Dear Scientist' video - Fierce Pharma Pfizer agrees to pay $93 mln to settle Lipitor antitrust lawsuit - Reuters Pfizer Awards $2M to Nonprofit Organizations Addressing Systemic Health Inequities - Pfizer European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited ... - Yahoo Finance Pfizer reports drop in revenue for full year 2023 - Pharmaceutical Technology PFIZER CEO: 'This is a great deal for America' - Yahoo Pfizer at AWS re:Invent 2023 | Lidia Fonseca, Keynote Speaker - Amazon.com Pfizer inflammatory bowel disease drug wins EU approval - Reuters Pfizer achieves novel EU approval for prostate cancer treatment - European Pharmaceutical Review How Pfizer Completely Dodged the Corporate Income Tax - Jacobin magazine Pfizer shares sink after it resets 2024 COVID expectations - Reuters Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff - BioSpace AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J - BioSpace EU approves new antibiotic to tackle rise of superbugs - Financial Times On the Shoulders of Giants - Pfizer Three Takeaways from Pfizer at AWS re:Invent Keynote | Amazon Web Services - AWS Blog Why the Market Dipped But Pfizer (PFE) Gained Today - Yahoo Finance Pfizer wins pause on Moderna's COVID-19 patent lawsuit - Reuters Pfizer accused of 'bringing discredit' on industry with 'unnecessary' vaccine tweet - biopharma-reporter.com Pfizer to price COVID treatment Paxlovid at $1390 per course - Reuters Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock - Yahoo Finance Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE) - Benzinga Business to Business - Pfizer Tackling Antibiotic Resistance - Pfizer Pfizer Inc. stock underperforms Wednesday when compared to competitors - MarketWatch 2023 In Review - Pfizer Pfizer Biotechnology Campus at Grange Castle Ireland expands - Pharmaceutical Technology VC firm Canaan adds $100M-plus for biotech bets and tacks on a Pfizer vet to gauge early science - Fierce Biotech Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know - CNBC Pfizer Celebrates Legacy, Justice, and Equity - Pfizer Pfizer Inc. stock underperforms Thursday when compared to competitors - MarketWatch Connect uncouples from Pfizer by scrapping eczema pact - Fierce Biotech Pfizer Plans to Sell About £2 Billion of Shares in Haleon - Yahoo Finance Lady Gaga's post about Pfizer Nurtec ODT ad earns EU ire - Fierce Pharma UT Southwestern collaborates with Pfizer to develop improved RNA delivery technologies - UT Southwestern Medical Center Pfizer RSV vaccine lags GSK's as head-to-head competition underway - Reuters Ex-Pfizer employee convicted of insider trading on COVID drug trial - Reuters Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive - BioSpace Pfizer Kicks Off 175th Anniversary by Looking Back at Legacy and Ahead to the Future - Pfizer Is Pfizer Stock, At A 9-Year Low, A Sell Amid The Search For Its Big Break? - Investor's Business Daily Pfizer ponies up $39M to resolve old pay-for-delay lawsuit - Fierce Pharma Pfizer sues Hungary as pandemic court cases mount - POLITICO Europe In Pfizer's trying year, CEO Albert Bourla takes 35% pay cut to $21.6M - Fierce Pharma From Pfizer to Pieper: With VDL on the defensive, who stands to gain? - The Parliament Magazine Pfizer appoints new chief IR officer - IR Magazine Pfizer's COVID outlook cuts hit other vaccine maker shares - Reuters EC approval for Pfizer's Emblaveo in multidrug-resistant infections - The Pharma Letter Pfizer: pharma group needs weight loss drug to secure post-Covid future - Financial Times Experts paint tough path ahead of Alnylam's key ATTR-CM readout - Fierce Pharma With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing - Digiday Fact Check: Preventing transmission never required for COVID vaccines' initial approval; Pfizer vax did reduce ... - Reuters Pfizer, Moderna say biotech, pharma drug development is a sprint - STAT Pfizer faces vote on human rights proposal | Governance intelligence - | Governance intelligence Pfizer beats earnings estimates as declining Covid business loses less revenue than expected - CNBC Pfizer Is Too Cheap To Ignore - Forbes Canaan hires Pfizer executive, reels in $100M for biotech investing - Yahoo Finance GSK sues Pfizer in US for patent infringement over RSV vaccine - Reuters Pfizer is about to make a big push in cancer. Will investors listen? - STAT Paxton sues Pfizer for not ending pandemic sooner - The Texas Tribune Pfizer’s year in review - Pfizer Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch Pfizer offloads $3.5 bln stake in Sensodyne-maker Haleon - Reuters Who can get a Covid booster this spring and how can you book? - BBC Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers. - Forbes Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24% - Reuters Lady Gaga 'shines' in 2nd Nurtec ODT ad for Pfizer - Fierce Pharma Pfizer to remain aggressive on obesity market after setback - Reuters Like Pfizer and BioNTech, Moderna scales back its African ambitions - The Africa Report.com Pfizer's blood cancer therapy Adcetris succeeds in late-stage trial - Reuters Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch Expired Pfizer Covid antiviral drugs set to cost Europe $2.2bn, data shows - Financial Times The Updated COVID Vaccines Are Here: 9 Things to Know - Yale Medicine Pfizer High-Containment-Anlage - Siemens Pfizer, BioNTech win pause in patent infringement case from rival Moderna - Fierce Pharma Pfizer shares tumble on weak forecast for 2024 revenues - Financial Times Pfizer's Velsipity UK approval to raise competition in ulcerative colitis market - biopharma-reporter.com Pfizer Impact: Responsible Business | Breakthroughs that change patients' lives - Pfizer EPIC-SR: The negative paxlovid data Pfizer has been sitting on - First10EM Pfizer slashes revenue forecast on lower COVID sales, will cut costs - Reuters Pfizer is suing Poland over vaccines. This is how we got here - POLITICO Europe EU approves Pfizer's new antibiotic EMBLAVEO By Investing.com - Investing.com Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space - BioSpace Pfizer to cut 500 jobs at UK site as part of wider cost cuts - Reuters Is Pfizer Stock a Buy? - Yahoo Finance Covid vaccine makers to clash in London over mRNA patent dispute - Financial Times CEO Albert Bourla Kicks Off Pfizer's 175th Anniversary Celebration - Pfizer Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 - Valneva Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice - Fierce Pharma Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights - Reuters Top Pfizer Shareholders - Investopedia U.S. jury clears Pfizer in second trial alleging Zoloft birth defects - Yahoo

由於pfizer內容廣泛，應用場合多樣化，因此專題介紹並沒有特定的結構和風格。pfizer專題介紹是就某些特定的人物事物，或事物的某些特定的範圍、層面作比較專門、深入介紹的文字。一般專題介紹以面向社會公眾為主，通常沒有十分明確的寫作對象。